Quantum BioPharma is trading at $3.69, up 12.84% in pre-market; no specific catalyst has been verified.
- The October 5 close was $3.27; recent closes had declined over several sessions.
- No October 6 announcement or specific catalyst was verified. The latest company-specific news was an October 2 report that Quantum BioPharma received final reports for two multiple-sclerosis drug candidate studies; evidence does not establish a connection to the move. Pre-market volume was unverified.